$ATRA Atara Biotherapeutics, Inc. Insider Trading Week 38/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Atara Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Atara Biotherapeutics, Inc. in week 38/2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 25 2015 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 43.06 | 1,500 | 64,590 | 402,411 | 403.9 K to 402.4 K (-0.37 %) |
Sep 25 2015 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 42.17 | 1,100 | 46,387 | 403,911 | 405 K to 403.9 K (-0.27 %) |
Sep 25 2015 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 43.29 | 2,600 | 112,554 | 405,011 | 407.6 K to 405 K (-0.64 %) |
Sep 21 2015 | ATRA | Atara Biotherapeut ... | SEIDENBERG BETH C | Director | Buy | J | 0.00 | 197 | 0 | 197 | 0 to 197 |
Sep 21 2015 | ATRA | Atara Biotherapeut ... | SEIDENBERG BETH C | Director | Buy | J | 0.00 | 197 | 0 | 197 | 0 to 197 |
Sep 21 2015 | ATRA | Atara Biotherapeut ... | SEIDENBERG BETH C | Director | Buy | J | 0.00 | 3,693 | 0 | 3,693 | 0 to 3.7 K |
Sep 21 2015 | ATRA | Atara Biotherapeut ... | SEIDENBERG BETH C | Director | Sell | J | 0.00 | 43,518 | 0 | 4,716 | 48.2 K to 4.7 K (-90.22 %) |
Sep 21 2015 | ATRA | Atara Biotherapeut ... | SEIDENBERG BETH C | Director | Buy | J | 0.00 | 48,234 | 0 | 48,234 | 0 to 48.2 K |
Sep 21 2015 | ATRA | Atara Biotherapeut ... | SEIDENBERG BETH C | Director | Sell | J | 0.00 | 8,700 | 0 | 54,422 | 63.1 K to 54.4 K (-13.78 %) |
Sep 21 2015 | ATRA | Atara Biotherapeut ... | SEIDENBERG BETH C | Director | Sell | J | 0.00 | 291,300 | 0 | 1,822,228 | 2.1 M to 1.8 M (-13.78 %) |